ARCHIVED Text Version PDF Version To Publications Page To Home Page
|
|
Title:Maine Drug Threat Assessment Update
Publication Date: April 2002Document ID: 2002-S0377ME-001
Available Maine Assessments
|
Contents |
||||
|
||||
|
||||
List of TablesTable 1. Drug-Related Treatment Admissions, Maine,
1995-2001 |
||||
OverviewThe distribution and abuse of diverted pharmaceuticals and illicit drugs pose serious threats to the safety of Maine residents. Diverted pharmaceuticals, primarily OxyContin and Dilaudid, have become the primary drug threat in the state. The high number of treatment admissions, seizures, and arrests associated with diverted pharmaceuticals illustrate the magnitude of the problem. Heroin, primarily South American, is the second most significant drug threat, and abuse continues to increase. The abuse of cocaine, which previously was the state's primary drug threat, is now relatively stable, although crack cocaine abuse is increasing in southern and central Maine. Marijuana is the most widely available and commonly abused drug in Maine; however, marijuana poses less of a threat than diverted pharmaceuticals, heroin, and cocaine because its effects are less debilitating and it is not commonly associated with violent crime. Other dangerous drugs, including LSD and MDMA, are popular among teenagers and young adults. Methamphetamine is available in limited quantities and is considered a low threat. |
||||
Addresses |
||||
National
Drug Intelligence Center Tel.
(814) 532-4601 |
National
Drug Intelligence Center 8201 Greensboro Drive, Suite 1001 McLean, VA 22102-3840 Tel. (703) 556-8970 |
|||
Web AddressesADNET: http://ndicosa |
End of page.